Citation: | SHI Rui, FENG Lei, TANG Ling-tong, ZHANG Chun-ting, LUO Bei-bei, BI Qian-ye, CAO Hui-ying, ZHANG Yan-bi. Research progress on evaluation indicators of blood glucose fluctuation in patients with diabetes[J]. Chinese Journal of General Practice, 2022, 20(12): 2105-2109. doi: 10.16766/j.cnki.issn.1674-4152.002780 |
[1] |
VALENTE T, ARBEX A K. Glycemic variability, oxidative stress, and impact on complications related to type 2 diabetes mellitus[J]. Curr Diabetes Rev, 2021, 17(7): e071620183816. DOI: 10.2174/1573399816666200716201550.
|
[2] |
高霜, 张艳丽, 吴姗姗, 等. 2型糖尿病患者的糖尿病痛苦现状调查及影响因素分析[J]. 中华全科医学, 2020, 18(12): 2136-2139. doi: 10.16766/j.cnki.issn.1674-4152.001707
GAO S, ZHANG Y L, WU S S, et al. Investigation on the current situation of diabetes pain in patients with type 2 diabetes and analysis of its influencing factors[J]. Chinese Journal of General Practice, 2020, 18(12): 2136-2139. doi: 10.16766/j.cnki.issn.1674-4152.001707
|
[3] |
中华医学会内分泌学分会. 糖尿病患者血糖波动管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(8): 633-636. doi: 10.3760/cma.j.issn.1000-6699.2017.08.002
Chinese Society of Endocrinology. Expert consensus on management of blood glucose fluctuation in patients with diabetes[J]. Chinese Journal of Endocrinology and Metabolism, 2017, 33(8): 633-636. doi: 10.3760/cma.j.issn.1000-6699.2017.08.002
|
[4] |
ZHANG Z Y, MIAO L F, QIAN L L, et al. Molecular mechanisms of glucose fluctuations on diabetic complications[J]. Front Endocrinol(Lausanne), 2019, 10: 640. doi: 10.3389/fendo.2019.00640
|
[5] |
周建华, 李晓华, 贝鹏剑, 等. 早期T2DM肾病患者血糖波动与氧化应激, 炎症及单核细胞自噬的相关性[J]. 中国老年学杂志, 2021, 41(1): 32-36. doi: 10.3969/j.issn.1005-9202.2021.01.009
ZHOU J H, LI X H, BEI P J, et al. The relationship between blood glucose fluctuation and oxidative stress, inflammation and monocyte autophagy in patients with early T2DM nephropathy[J]. Chinese Journal of Gerontology, 2021, 41(1): 32-36. doi: 10.3969/j.issn.1005-9202.2021.01.009
|
[6] |
中华医学会糖尿病学分会. 中国血糖监测临床应用指南(2021年版)[J]. 中华糖尿病杂志, 2021, 13(10): 936-948. doi: 10.3760/cma.j.cn115791-20210810-00436
Chinese Diabetes Society. Guidelines for clinical application of blood glucose monitoring in China(2021)[J]. Chinese Gournal of Diabetes Mellitus, 2021, 13(10): 936-948. doi: 10.3760/cma.j.cn115791-20210810-00436
|
[7] |
SHEN Y, DAI D J, LU J Y, et al. Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease[J]. Cardiovasc Diabetol, 2020, 19(1): 211. doi: 10.1186/s12933-020-01187-1
|
[8] |
FLEISCHER J, CICHOSZ S L, HANSEN T K. Comment on Lachin et al. Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complications trial[J]. Diabetes Care, 2017, 40(11): e164. DOI: 10.2337/dc17-1339.
|
[9] |
BABAYA N, NOSO S, HIROMINE Y, et al. Flash glucose monitoring in type 1 diabetes: A comparison with self-monitoring blood glucose[J]. J Diabetes Investig, 2020, 11(5): 1222-1229. doi: 10.1111/jdi.13229
|
[10] |
LU J Y, MA X J, ZHANG L, et al. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study[J]. Diabetes Res Clin Pract, 2020, 161: 108032. DOI: 10.1016/j.diabres.2020.108032.
|
[11] |
TSENG J Y, CHEN H H, HUANG K C, et al. Effect of mean HbA1c on the association of HbA1c variability and all-cause mortality in patients with type 2 diabetes[J]. Diabetes Obes Metab, 2020, 22(4): 680-687. doi: 10.1111/dom.13951
|
[12] |
CERIELLO A, LUCISANO G, PRATTICHIZZO F, et al. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target[J]. Cardiovasc Diabetol, 2022, 21(1): 13. doi: 10.1186/s12933-022-01445-4
|
[13] |
ZINMAN B, MARSO S P, POULTER N R, et al. Day-to-day fasting glycaemic variability in DEVOTE: Associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)[J]. Diabetologia, 2018, 61(1): 48-57. doi: 10.1007/s00125-017-4423-z
|
[14] |
BI J N, SONG L L, WANG L L, et al. Visit-to-visit fasting blood glucose variability and lifetime risk of cardiovascular disease: A prospective study[J]. Cardiovasc Diabetol, 2021, 20(1): 207. doi: 10.1186/s12933-021-01397-1
|
[15] |
ECHOUFFO-TCHEUGUI J B, ZHAO S, BROCK G, et al. Visit-to-visit glycemic variability and risks of cardiovascular events and all-cause mortality: The ALLHAT study[J]. Diabetes Care, 2019, 42(3): 486-493. doi: 10.2337/dc18-1430
|
[16] |
SU J B, ZHAO L H, ZHANG X L, et al. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients[J]. Cardiovasc Diabetol, 2018, 17(1): 47. doi: 10.1186/s12933-018-0693-0
|
[17] |
LEE C L, CHEN C H, WU M J, et al. The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes[J]. Ther Adv Chronic Dis, 2020, 11: 2040622319898370. DOI: 10.1177/2040622319898370.
|
[18] |
HU J Q, HSU H C, YUAN X D, et al. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes[J]. J Endocrinol Invest, 2021, 44(6): 1229-1236. doi: 10.1007/s40618-020-01410-6
|
[19] |
HSIEH Y T, HSIEH M C. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study[J]. Clin Exp Ophthalmol, 2020, 48(4): 470-476. doi: 10.1111/ceo.13728
|
[20] |
BENALIA M, ZELLER M, MOUHAT B, et al. Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction[J]. Diabetes Metab, 2019, 45(5): 446-452. doi: 10.1016/j.diabet.2019.01.012
|
[21] |
GERBAUD E, DARIER R, MONTAUDON M, et al. Glycemic variability is a powerful independent predictive factor of midterm major adverse cardiac events in patients with diabetes with acute coronary syndrome[J]. Diabetes Care, 2019, 42(4): 674-681. doi: 10.2337/dc18-2047
|
[22] |
LACHIN J M, BEBU I, BERGENSTAL R M, et al. Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complications trial[J]. Diabetes Care, 2017, 40(6): 777-783. doi: 10.2337/dc16-2426
|
[23] |
LU J Y, MA X J, ZHANG L, et al. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes[J]. J Diabetes Investig, 2019, 10(3): 753-759. doi: 10.1111/jdi.12957
|
[24] |
JUN J E, LEE S E, LEE Y B, et al. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients[J]. Cardiovasc Diabetol, 2017, 16(1): 127. doi: 10.1186/s12933-017-0619-2
|
[25] |
PAN J M, YAN X F, LI F W, et al. Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients[J]. J Diabetes Investig, 2022, 13(2): 328-335. doi: 10.1111/jdi.13652
|
[26] |
CHAN C L, PYLE L, KELSEY M M, et al. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes[J]. Pediatr Diabetes, 2017, 18(7): 629-636. doi: 10.1111/pedi.12475
|
[27] |
WANG B R, YAO J T, ZHENG H, et al. Association of glycated albumin/glycosylated hemoglobin ratio with blood glucose fluctuation and long-term blood glucose control in patients with Type 2 diabetes mellitus[J]. Diabetes Metab Syndr Obes, 2021, 14: 1809-1815. doi: 10.2147/DMSO.S297730
|
[28] |
FENG L, NIAN S Y, ZHAO Y, et al. Higher HbA1c and/or glucose levels alter the association patterns between glycated hemoglobin and fasting glucose levels[J]. Diabetes Res Clin Pract, 2018, 142: 353-362. doi: 10.1016/j.diabres.2018.06.011
|